Effects of genetic polymorphisms of CYP2D6, CYP3A5, and ABCB1 on the steady-state plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia - Suzuki, T; Mihara, K; Nakamura, A (Ther Drug Monit, 2014)
et al.